FIELD: chemistry.
SUBSTANCE: invention relates to novel flavonoid compounds of formula 1
where R1-R5 assume values given in the description. The invention also relates to a pharmaceutical composition based on said compounds and a treatment and prevention method. Such compounds and corresponding pharmaceutically acceptable derivatives and/or salts are used in pharmaceutical, veterinary and nutraceutical fields.
EFFECT: compounds and compositions have antioxidant properties and are especially effective in treating ischemic and reperfusion injury.
39 cl, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SELECTIVE BUTYRYLCHOLIN ESTERASE INHIBITORS | 2005 |
|
RU2386627C2 |
| NEW COMPOUNDS OF FLAVONOIDS AND THEIR APPLICATION | 2013 |
|
RU2647842C2 |
| TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
| PHENOXYPHENYL ACETIC ACID | 1994 |
|
RU2139273C1 |
| DERIVATIVES OF 2-DEOXY-2,3-DIDEHYDRO-N-ACETYLNEURAMINIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1991 |
|
RU2119487C1 |
| HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND APPLICATION METHOD THEREOF | 2007 |
|
RU2430101C2 |
| METHOD OF TREATING VASCULAR LEAK SYNDROME | 2010 |
|
RU2539917C2 |
| BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2508113C2 |
| NAPHTHYL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES | 1996 |
|
RU2167849C2 |
| INDOLYLMALEIMIDE DERIVATIVES | 2005 |
|
RU2373201C2 |
Authors
Dates
2011-10-20—Published
2006-03-10—Filed